A case of IPD was defined by the isolation of S. pneumoniae from a normally sterile site. Microbiological investigations Isolates were identified by standard procedures

including bile solubility and optochin sensitivity. Minimal inhibitory concentrations (MIC) testing was performed using the broth microdilution method as recommended by the Clinical and Laboratory Standards Institute (CLSI) [7]. Macrolide resistance was investigated using erythromycin or clarithromycin, in which testing with erythromycin was replaced by Adriamycin nmr clarithromycin over the years. 425 isolates were tested both for erythromycin and clarithromycin. The susceptible, intermediate, and resistant breakpoints (MIC) were ≤ 0.25, 0.5, and ≥1 μg/ml, both for erythromycin and clarithromycin find more [7]. Streptococcus pneumoniae ATCC 49619 was used as a control strain. Statistical analysis All categorical data were expressed as frequencies. To analyse a severe increase or decrease over time the Cochran-Armitage test was used. The overall significance level was adjusted using the Bonferroni

correction to account for the problem of multiple testing. Due to 14 tests p-values ≤ 0.0036 were considered as statistically significant test results. All statistical analyses were conducted using SAS Version 9.1.3 (SAS Institute Inc., Cary, NC, USA). Results In total, 12,136 isolates from invasive pneumococcal disease were collected between January 1, 1992 and December 31, 2008. The number of cases for each year vary between 297 and 2,037 (median: 505 cases). Data on macrolide susceptibility were available for 11,807 Erastin concentration isolates, whereas 8,834 isolates (74.8%) JAK inhibition originated from adults, 2,973 isolates (25.2%) were from children. The overall nonsusceptibility rate of all isolates was 16.2% (intermediate, 0.2%; resistant, 16.0%). Higher resistance rates were observed among children (intermediate, 0.2%; resistant, 23.8%) than among adults (intermediate, 0.3%; resistant 13.4%) (Table 1).

Table 1 Ranking of serotype specific macrolide nonsusceptibility among IPD isolates in Germany from 1992 to 2008 (n, overall = 11,807; n, adults = 8,834; n, children = 2,973)   children adults overall Sero type I% R% S% total (n) I% R% S% total (n) I% R% S% total † (n) total ‡ (%) 14 0.0 67.4 32.6 663 0.2 71.0 28.8 883 0.1 69.5 30.4 1546 16.4 45 – - – - 0.0 33.3 66.7 3 0.0 33.3 66.7 3 0.0 19B 0.0 0.0 100.0 1 0.0 50.0 50.0 2 0.0 33.3 66.7 3 0.0 rough 0.0 25.0 75.0 8 0.0 40.0 60.0 10 0.0 33.3 66.7 18 0.2 6B 0.0 29.3 70.7 215 0.4 36.2 63.4 232 0.2 32.9 66.9 447 4.8 15A 4.8 28.6 66.7 21 0.0 33.3 66.7 27 2.1 31.3 66.7 48 0.5 19F 0.0 24.5 75.5 212 0.4 27.5 72.0 236 0.2 26.1 73.7 448 4.8 19A 0.0 24.4 75.6 90 0.9 26.0 73.2 231 0.6 25.5 73.8 321 3.4 10B – - – - 0.0 20.0 80.0 10 0.0 20.0 80.0 10 0.1 19C 0.0 0.0 100.0 2 0.0 33.3 66.7 3 0.0 20.0 80.0 5 0.1 15B 0.0 23.1 76.9 26 0.0 17.5 82.5 57 0.0 19.3 80.7 83 0.9 23F 0.5 20.4 79.1 201 0.6 18.3 81.2 356 0.5 19.0 80.4 557 5.9 9V 0.